Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
about
Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisOptimal management of steroid-dependent ulcerative colitisMedical Therapy of Active Ulcerative ColitisReview article: dose optimisation of infliximab for acute severe ulcerative colitis.Severe Henoch-Schönlein purpura with infliximab for ulcerative colitisStep-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitisFecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis.Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.Cultured blood T-cell responses predict anti-TNF therapy response in patients with ulcerative colitis.The biologics of ulcerative colitis.Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.Letter: anti-TNF in steroid-dependent ulcerative colitis - are the available data enough?Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experience.
P2860
Q26764801-C9B8F8C3-3066-4751-89D2-A94B3D3C0E77Q26773203-C2BDDF46-7EFF-4B31-A5BA-CEEA56B02899Q26777729-7552A446-1BC3-4B51-B7BC-B512EE6A52D7Q30239077-619C86CC-8D5A-4C5E-A4F3-C2135ACC48A4Q35625482-84775F58-594A-40A4-BBCD-4FD404FC45BDQ35771699-58FAA6FE-B4BE-40BF-9313-94D99EE07580Q36793729-15AE1A00-1AB5-4F5D-A4A4-9F2BC4A38F07Q38287132-1CC9ADD4-D0E5-499F-BE34-2CF0AB39E28FQ38816194-285BE63C-98E3-4CB3-B1E1-A8DCFDF8232DQ38822920-84D6086A-1732-4C05-8834-ADE2D8FC1FA8Q39019746-BAD5C58C-BE30-4221-BB21-14E1E496DF55Q39037681-15570734-90B6-4A70-80C6-B4F3CAE3D047Q40708429-859CFCD2-3957-4D32-BBCB-7C7903589D9BQ41520678-7D35ADEF-95F7-4AA0-B561-819C9F1B3AACQ42616840-ED4C74D3-773F-46B6-8BAA-B9F7024F3969Q47130594-EE57169A-113D-47B7-BB8B-7D5A107C430BQ48194119-81DF71DF-E46E-496E-8342-F7BAAA2DD980Q48216172-9C64C75E-852E-40C9-BD97-4C4148182EE1Q51063874-02C8A7C7-09BE-4D73-91E4-A2FA82BBA252
P2860
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Long-term combination therapy ...... -dependent ulcerative colitis.
@en
Long-term combination therapy ...... -dependent ulcerative colitis.
@nl
type
label
Long-term combination therapy ...... -dependent ulcerative colitis.
@en
Long-term combination therapy ...... -dependent ulcerative colitis.
@nl
prefLabel
Long-term combination therapy ...... -dependent ulcerative colitis.
@en
Long-term combination therapy ...... -dependent ulcerative colitis.
@nl
P2093
P2860
P50
P1476
Long-term combination therapy ...... -dependent ulcerative colitis.
@en
P2093
Alessandro Armuzzi
Gian Lodovico Rapaccini
Gianluca Andrisani
Gianluca Rizzo
Italo De Vitis
Manuela Marzo
Olga Maria Nardone
Silvio Danese
P2860
P304
P356
10.1097/MIB.0000000000000115
P577
2014-08-01T00:00:00Z